Innovaderm Research

What Innovaderm Research does

Innovaderm Research is a Montreal-based, dermatology-focused clinical research organization founded in 2000 by Dr. Robert Bissonnette. The company operates a dual structure: (1) a Clinical Research Unit (CRU) that recruits and treats patients with skin conditions in a state-of-the-art clinic featuring 16 exam rooms, a fully equipped pharmacy, and specialized dermatology equipment; and (2) Indero (formerly Innovaderm CRO), a full-service Contract Research Organization rebranded in 2025 that manages dermatology and rheumatology clinical trials for pharmaceutical and biotech sponsors.

The company generates revenue primarily through professional services fees billed to pharma and biotech sponsors for clinical trial execution, patient recruitment, site management, and data collection. It also runs participant-paid studies (compensation ranging from $375 to $7,350 depending on visit count and duration) approved by Health Canada and ethics committees. Its go-to-market is sales-led for sponsors and community-led for patient recruitment, leveraging multi-channel marketing including website enrollment, radio advertising across major Montreal stations, STM public transit ads, social media, and physician referral networks. The company has completed 500+ clinical trials across 25+ years and is ranked among the top 10 research clinics globally for completed eczema trials per Trialhub.

Innovaderm is a privately held firm with 11-50 employees and no disclosed institutional investors, parent company, or funding rounds. Its core technical assets are concentrated in its physical infrastructure (award-winning clinic design) and investigator talent, including Dr. Bissonnette (nearly 200 studies conducted, 270+ publications) and two additional board-certified dermatologists. The company is CCPA and GDPR compliant and serves North American markets (Canada and US).

Name

Innovaderm Research

Legal name

Innovaderm Research Inc.

Website

https://innovaderm.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Innovaderm Research is a Montreal-based dermatology-focused Clinical Research Unit (CRU) that recruits patients with skin conditions for clinical trials and operates Indero, a CRO managing dermatology and rheumatology studies for pharma and biotech sponsors.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

akta.pro secondary industries

Clinical CROs (Phase I–IV) (HLAGAAAA), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Dermatology clinical research
• Contract research organization
• Clinical trial services
• Patient recruitment
• Rheumatology trials

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Clinical Trial Services (CRO): Contract research services provided to pharmaceutical and biotech sponsors conducting dermatology and rheumatology clinical trials. Full-service CRO combined with expert clinical sites. Revenue generated through clinical research service fees billed to study sponsors.
2. Patient Participation Studies: Clinical research unit conducting studies where patients with dermatological conditions participate in exchange for financial compensation. Studies approved by Health Canada and ethics committees.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Innovaderm Research operates a dermatology-focused Clinical Research Unit (CRU) in Montreal that recruits patients with skin conditions to participate in clinical studies, while its CRO arm (recently rebranded to Indero) provides full-service contract research organization services to pharmaceutical and biotech sponsors conducting dermatology and rheumatology clinical trials. The organization combines a state-of-the-art clinic facility (16 exam rooms, fully equipped pharmacy) with comprehensive CRO capabilities for trial execution, patient recruitment, site management, and data collection.

Product overview

Innovaderm Research operates as a dual-entity organization: (1) Innovaderm Research CRU - a dermatology-focused Clinical Research Unit providing patient participation services for clinical studies, and (2) Indero CRO - a rebranded full-service CRO managing clinical trials in dermatology and rheumatology. The company conducts 500+ clinical trials across 25+ years, offering patients with skin conditions opportunities to participate in research while supporting pharmaceutical sponsors in developing new therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Innovaderm Research Clinical Research Unit (CRU)
• Indero CRO Services
• Clinical Trial Participation Services

Quantifiable outcome

• 500+ clinical trials completed since 2000
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Research Centers in US and CanadaminorStrategic or Co-development Partner · 1 January 2004In 2004, Innovaderm partnered with research centers in the US and Canada to offer access to more high-quality dermatology sites, expanding their network of clinical research facilities.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Medpace: Mid-to-large full-service CRO with strong therapeutic-area expertise across multiple specialties including dermatology; comparable as a sponsor-facing CRO though it offers broader multi-therapeutic capabilities and global scale.
• Parexel: Global CRO with established dermatology and rheumatology practices; comparable as a competitor for sponsor dermatology studies though operating at significantly larger scale and across broader geographies.
• ICON plc: Global full-service CRO with dermatology and rheumatology capabilities; comparable as a competitor for dermatology trial mandates though offering broader scale and geographic reach.
• IQVIA: Largest global CRO with broad dermatology capabilities; comparable as a competitor for sponsor dermatology trials though it operates at materially larger scale and across all therapeutic areas.

Direct peers

• Worldwide Clinical Trials: Mid-sized specialty-focused CRO with therapeutic-area expertise including immunology and dermatology; comparable as a sponsor-facing CRO competing for dermatology trial mandates with similar scale and specialty positioning.
• Premier Research: Specialty CRO with established dermatology and rare disease capabilities serving small and mid-sized biotech sponsors; directly comparable in therapeutic focus, customer profile, and trial execution model.
• Celerion: Specialty clinical research services provider with early-phase and therapeutic-area expertise; comparable as a specialty CRO serving pharmaceutical sponsors with focused therapeutic capabilities.
• Indero (formerly Innovaderm CRO): The CRO arm spun out of Innovaderm Research in 2025; offers full-service dermatology and rheumatology CRO services. Directly comparable in therapeutic focus and customer base, and shares historical track record with Innovaderm.
• Synteract (now part of Precision for Medicine): Mid-sized CRO with dermatology and specialty therapeutics experience serving biotech sponsors; directly comparable in therapeutic focus and mid-tier CRO positioning.
• Rho: Specialty CRO focused on clinical research for therapeutic areas including immunology and dermatology; comparable in mid-tier CRO positioning and sponsor relationships with biotech clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Innovadermrecherche
• LinkedInlinkedin.com/company/innovaderm-research
• Instagraminstagram.com/innovaderm__

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovaderm Research